Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Semiquantitative mIBG Scoring as a Prognostic Indicator in Patients with Stage 4 Neuroblastoma: A Report from the Children’s Oncology Group

25 Feb 2013

Abstract excerpt

UNLABELLED: Radiolabeled metaiodobenzylguanidine (mIBG) is a highly sensitive and specific marker for detecting neuroblastoma. A semiquantitative mIBG score (Curie score [CS]) was assessed for utility as a prognostic indicator for a cohort of patients with high-risk metastatic disease. METHODS: mIBG scans from 280 patients with mIBG-avid, stage 4 neuroblastoma enrolled on the Children's Oncology Group (COG)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenal and Paraganglionic Tumors
Share to Cancer, Hypoxia, and Metabolism
Share to Neuroblastoma Research and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23440556
DOI: 10.2967/jnumed.112.112334

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Semiquantitative mIBG Scoring as a Prognostic Indicator in Patients with Stage 4 Neuroblastoma: A Report from the Children’s Oncology GroupPMID 23440556Read ↗

Significance of <i>MYCN</i> Amplification in International Neuroblastoma Staging System Stage 1 and 2 Neuroblastoma: A Report From the International Neuroblastoma Risk Group DatabaseSemantic proximity Read ↗

Combination of minimal residual disease and 123 I-Metaiodobenzylguanidine scintigraphy in monitoring of neuroblastoma metastasesSemantic proximity Read ↗

Defining Risk Factors for Chemotherapeutic Intervention in Infants With Stage 4S Neuroblastoma: A Report From Children’s Oncology Group Study ANBL0531Semantic proximity Read ↗

Outcome after Reduced Chemotherapy for Intermediate-Risk NeuroblastomaSemantic proximity Read ↗

MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: the Italian experience with 295 children.Semantic proximity Read ↗

Value of surgical resection in children with high‐risk neuroblastomaSemantic proximity Read ↗

A Clinicobiological Model Predicting Survival in MedulloblastomaSemantic proximity Read ↗

Evaluation of Norepinephrine Transporter Expression and Metaiodobenzylguanidine Avidity in Neuroblastoma: A Report from the Children's Oncology GroupSemantic proximity Read ↗

Validation of the mIBG skeletal SIOPEN scoring method in two independent high-risk neuroblastoma populations: the SIOPEN/HR-NBL1 and COG-A3973 trialsSemantic proximity Read ↗

β-1,4-Galactosyltransferase III enhances invasive phenotypes via β1-integrin and predicts poor prognosis in neuroblastoma.Semantic proximity Read ↗

Influence of neuroblastoma stage on serum‐based detection of <i>MYCN</i> amplificationSemantic proximity Read ↗

Nothing but NET: A review of norepinephrine transporter expression and efficacy of<sup>131</sup>I‐mIBG therapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.